Breakthroughs Blog

Breakthroughs brings you stories of bright ideas and bold innovations in global health.

The Latest
Ansley Kahn
Research Roundup: Pregnant women in DRC to be given Ebola vaccine, releases of genetically modified mosquitoes in high-security lab, and CRISPR may help against viruses for which no vaccine exists

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Recent

PATH/Wendy Stone
Research Roundup: A promising malaria vaccine, a virulent new form of HIV, climate change, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
DNDi/João Roberto Ripper
Chagas disease: A silent kiss and a neglected killer

Valentine’s Day seems like a fitting occasion to shine some needed light on a disease that can begin with a late-night “kiss” but ends with a broken heart.

Read More
PATH/Wendy Stone
Research Roundup: FDA Commissioner to step down, a Grand Challenge for neglected diseases, funding for reproductive health research and development, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
WHO Executive Board agrees on set-up of pooled fund for global health R&D

In this guest post, Alexandra Heumber—head of policy affairs at the Drugs for Neglected Diseases initiative—discusses actions taken during the World Health Organization (WHO)’s Executive Board meeting which could impact financing for the research and development (R&D) of new health technologies for developing countries.

Read More
Obama Administration’s FY2016 budget presents mixed outlook for global health R&D

On Monday the White House turned heads by releasing, for the first time since 2010, an on-time budget. Overall the White House presented a mixed outlook for global health research and development (R&D).

GHTC
Read More
The state of reproductive health R&D for developing countries

In this guest post, Dale Halliday—an analyst at Policy Cures—discusses the finding of Policy Cures’ report on funding for reproductive health technology research and development (R&D) in developing countries.

Policy Cures
Read More
PATH/Mike Wang
Research Roundup: The 21st Century Cures Act, US funding for antimicrobial resistance, vaccine development and funding, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Evelyn Hockstein
Research Roundup: Ebola vaccine trials in Liberia, the spread of insect-borne tropical diseases, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Obama highlights global health and innovation in State of the Union address

While others were playing State of the Union bingo or creating pretty word clouds, GHTC was closely watching the State of the Union address to see what President Barack Obama would say about US engagement in global health and America’s leadership in science and innovation.

Read More
PATH/Will Boase
Research Roundup: Clinical trial data sharing, vaccines to look forward to, and public-private partnerships for global health research and development

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Gabe Bienczycki
Research Roundup: MenAfriVac® prequalification, an innovative new antibiotic, Ebola vaccine trials, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
10 reasons why the US policymakers should support global health research and development

At the Global Health Technologies Coalition, our mission is to advance—through advocacy—the research and development (R&D) of new tools to prevent, diagnose, and treat global diseases.

Read More
PATH/Evelyn Hockstein
Research Roundup: Experimental Ebola vaccines and treatments, HIV prevention research, and an 18-year high in drug approvals

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Budget compromise reached: How did global health R&D fare?

Working over a rare weekend session and racing against the clock to keep the government open, Congress finally came to an agreement on a year-long spending plan to fund the government through September 30, 2015 (with the exception of the Department of Homeland Security, which only goes through February 27).

GHTC
Read More
CDC/James Gathaney
Research Roundup: R&D funding for neglected diseases, antimicrobial drug resistance, immunity for Ebola vaccine makers, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Aaron Joel Santos
Research Roundup: a weakened HIV virus, SDGs, powdered measles vaccine, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Doune Porter
Research Roundup: Gates Foundation open access policy, Ebola vaccine market, World AIDS Day, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Evelyn Hockstein
Research Roundup: Drug development costs, the price of priority review, new clinical trial requirements, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
Ten global health advancements I’m thankful for this Thanksgiving

As global health advocates, our work often requires us to focus on unmet needs—such as the number of people worldwide who still die from preventable diseases each year, or the lack of adequate resources and investment to tackle these diseases.

Read More
PATH/Eric Becker
Research Roundup: Malaria eradication, indemnity for Ebola vaccine manufacturers, drug development impediments, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More